Suchergebnisse - "Barlesi, F"

PubPharm (9)

1

Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Chen, J. | Facchinetti, F. | Braye, F. | +19

2

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Blons, H. | Oudart, J. | Merlio, J. | +18

3

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation : results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Leduc, C. | Merlio, J. | Besse, B. | +18

4

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs : results from the European EUHER2 cohort

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Mazières, J. | Barlesi, F. | Filleron, T. | +16

5

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients : results of an open-label, randomized, controlled phase II study (CERTO)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Vansteenkiste, J. | Barlesi, F. | Waller, C. | +16

6

Management of patients with resistance to EGFR-TKI

enthalten in: Revue de pneumologie clinique | 2011

von Barlesi, F.

7

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX) : an open-label randomised phase III trial

enthalten in: Lancet (London, England) | 2009

von Pirker, R. | Pereira, J. | Szczesna, A. | +116

CommentIn: Lancet. 2009 May 2;373(9674):1497-8. - PMID 19410696

8

Targeting HER pathway in head and neck and thoracic cancers

enthalten in: Bulletin du cancer | 2009

von Barlesi, F. | Breen, D.

9

Targeted therapies. New hopes, new challenges

enthalten in: Revue des maladies respiratoires | 2008

von Barlési, F.

1
[1]